Vyvanse Shortage December 2024. In october 2022, the fda announced a shortage of adderall. Takeda pharmaceuticals australia has notified us that due to the increase in demand for other strengths, vyvanse (lisdexamfetamine dimesilate) 40 mg will be in shortage.
Nearly 18 months after the fda first acknowledged a national shortage of adderall,. Takeda pharmaceuticals australia has notified us that due to the increase in demand for other strengths, vyvanse (lisdexamfetamine dimesilate) 40 mg will be in shortage.